Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients
Status:
Terminated
Trial end date:
2021-03-30
Target enrollment:
Participant gender:
Summary
1. To compare patient-reported satisfaction, efficacy and short-term safety profile of
Monofer® in a single bolus dose with Venofer® in split doses in the treatment of
absolute or functional iron deficiency anemia in patients on PD.
2. To compare patient symptomatology on fatigue after treatment of Monofer® compared with
Venofer® .
Phase:
N/A
Details
Lead Sponsor:
The University of Hong Kong
Treatments:
Ferric Compounds Ferric Oxide, Saccharated Iron Iron isomaltoside 1000